Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 956

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 3
Chunk 956
---
 CASH FLOWS FROM INVESTING ACTIVITIES 

    Capitalization of Patents 
     (51,967) 
     (39,982)
  
    Purchases of Fixed Assets 
     (103,773) 
     (57,623)
  
    Acquisition of Intangibles 
     (25,374) 
     (18,283)
  
    Purchase of Short-Term Investments 
     (1,708,000) 
     - 
  
    Net Cash Used in Investing Activities 
     (1,889,114) 
     (115,888)

    CASH FLOWS FROM FINANCING ACTIVITIES 

    Net Proceeds from January 2024 Offering 
     1,898,296  
     - 
  
    Proceeds from IPO and Over-Allotment, net of underwriting discounts, commissions, and deferred offering costs paid in 2023 of $1,198,111 
     -  
     6,303,905 
  
    Proceeds from ATM Offering, net of offering costs paid at closing and deferred offering costs of $264,774 
     1,729,810  
     - 
  
    Proceeds from Private Placement, net of offering costs paid at closing and deferred offering costs of $582,600 
     3,414,502  
     - 
  
    Proceeds from Exercise of Warrants 
     -  
     1,131,771 
  
    Proceeds from Exercise of Pre-Funded Warrants 
     10,963  
     - 
  
    Proceeds from Notes Payable 
     -  
     650,000 
  
    Repayment of Notes Payable 
     -  
     (1,611,111)
  
    Proceeds from Advances - Related Party 
     -  
     250,000 
  
    Repayment of Related Party Advances 
     -  
     (250,000)
  
    Net Cash Provided by Financing Activities 
     7,053,571  
     6,474,565 

    Effect of Exchange Rate Changes on Cash 
     499  
     61,853 

    Change in Cash and Cash Equivalents 
     (483,132) 
     1,877,620 
  
    Cash and Cash Equivalents—